NASDAQ:INCY

Incyte Corporation Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$57.05

+0 (+0%)

At Close: May 15, 2024

Currently predicting for Thu, 16 May 2024

Trading levels for INCY

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	57.75	1.23 %
		R2	57.50	0.788 %
		R1	57.34	0.512 %
Current price:			57.05
	Support	S1	56.83	-0.378 %
		S2	56.68	-0.653 %
		S3	56.42	-1.10 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	58.37	2.31 %
		R2	58.36	2.30 %
		R1	57.60	0.96 %
Current price			57.05
	Support	S1	52.94	-7.20%
		S2	52.56	-7.87%
		S3	52.05	-8.76%

INCY Predictions History

5 years ago
Emilio.Tabja.24943 predicted that INCY for 2018-05-22 is going $57.16 (-15.73%)

Rank:

About Incyte Corporation

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr... INCY Profile

Golden Star

Ticker	Date	Change	Price
GMAB	May 13	3.64%	$29.16
MCD	May 13	0.94%	$271.32
ITUB	May 13	0.93%	$6.42
BR	May 13	2.18%	$197.80
HLN	May 13	1.94%	$8.25
BJRI	May 10	6.01%	$33.75
LBTYA	May 10	2.93%	$16.71
LBTYK	May 10	1.97%	$17.23
DYN	May 10	13.00%	$26.00
KRC	May 10	3.88%	$34.02

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In